Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Kushner

Showing results (311-320 of 341) with videos related to

Pageof 35
Sort By:
F1000Research|January 8, 2019
ranacapa: An R package and Shiny web app to explore environmental DNA data with exploratory statistics and interactive visualizationsGaurav S Kandlikar, Zachary J Gold, Madeline C Cowen, et al.
Clinical and Experimental Pharmacology & Physiology. Supplement|November 11, 1998
Molecular and structural biology of thyroid hormone receptorsJ W Apriletti, R C Ribeiro, R L Wagner, et al.
Recent Progress in Hormone Research|October 14, 1998
Mechanisms of thyroid hormone action: insights from X-ray crystallographic and functional studiesR C Ribeiro, J W Apriletti, R L Wagner, et al.
Cancer Research|August 3, 2005
Cyclin D1 antagonizes BRCA1 repression of estrogen receptor alpha activityChenguang Wang, Saijun Fan, Zhiping Li, et al.
Molecular Endocrinology (Baltimore, Md.)|October 17, 1998
Estrogen receptor activation function 1 works by binding p160 coactivator proteinsP Webb, P Nguyen, J Shinsako, et al.
Cancer Research|January 10, 2002
p300 Modulates the BRCA1 inhibition of estrogen receptor activitySaijun Fan, Yong Xian Ma, Chenguang Wang, et al.
Oncogene|March 13, 2001
Role of direct interaction in BRCA1 inhibition of estrogen receptor activityS Fan, Y X Ma, C Wang, et al.
Biorxiv : the Preprint Server for Biology|April 3, 2026
PRINCIPLES GOVERNING ENDOTHELIAL CAVEOLAE ORGANIZATION DURING ANGIOGENESISDrew B Grespin, Jasper S Farrington, Talen G Niven, et al.
Nature Communications|May 17, 2018
Quantifying climate feedbacks in polar regionsHugues Goosse, Jennifer E Kay, Kyle C Armour, et al.
Molecular Cancer Therapeutics|December 16, 2023
Palazestrant (OP-1250), A Complete Estrogen Receptor Antagonist, Inhibits Wild-type and Mutant ER-positive Breast Cancer Models as Monotherapy and in CombinationAlison D Parisian, Susanna A Barratt, Leslie Hodges-Gallagher, et al.
Pageof 35

Showing results (311-320 of 341) with videos related to

Sort By:
Pageof 35
F1000Research|January 8, 2019
ranacapa: An R package and Shiny web app to explore environmental DNA data with exploratory statistics and interactive visualizationsGaurav S Kandlikar, Zachary J Gold, Madeline C Cowen, et al.
Clinical and Experimental Pharmacology & Physiology. Supplement|November 11, 1998
Molecular and structural biology of thyroid hormone receptorsJ W Apriletti, R C Ribeiro, R L Wagner, et al.
Recent Progress in Hormone Research|October 14, 1998
Mechanisms of thyroid hormone action: insights from X-ray crystallographic and functional studiesR C Ribeiro, J W Apriletti, R L Wagner, et al.
Cancer Research|August 3, 2005
Cyclin D1 antagonizes BRCA1 repression of estrogen receptor alpha activityChenguang Wang, Saijun Fan, Zhiping Li, et al.
Molecular Endocrinology (Baltimore, Md.)|October 17, 1998
Estrogen receptor activation function 1 works by binding p160 coactivator proteinsP Webb, P Nguyen, J Shinsako, et al.
Cancer Research|January 10, 2002
p300 Modulates the BRCA1 inhibition of estrogen receptor activitySaijun Fan, Yong Xian Ma, Chenguang Wang, et al.
Oncogene|March 13, 2001
Role of direct interaction in BRCA1 inhibition of estrogen receptor activityS Fan, Y X Ma, C Wang, et al.
Biorxiv : the Preprint Server for Biology|April 3, 2026
PRINCIPLES GOVERNING ENDOTHELIAL CAVEOLAE ORGANIZATION DURING ANGIOGENESISDrew B Grespin, Jasper S Farrington, Talen G Niven, et al.
Nature Communications|May 17, 2018
Quantifying climate feedbacks in polar regionsHugues Goosse, Jennifer E Kay, Kyle C Armour, et al.
Molecular Cancer Therapeutics|December 16, 2023
Palazestrant (OP-1250), A Complete Estrogen Receptor Antagonist, Inhibits Wild-type and Mutant ER-positive Breast Cancer Models as Monotherapy and in CombinationAlison D Parisian, Susanna A Barratt, Leslie Hodges-Gallagher, et al.
Pageof 35